共 208 条
[1]
Caiola E(2012)KRas-LCS6 polymorphism does not impact on outcomes in ovarian cancer Am J Cancer Res 2 298-308
[2]
Rulli E(2012)KRAS rs61764370 is associated with HER2-overexpressed and poorly-differentiated breast cancer in hormone replacement therapy users: a case control study BMC Cancer 12 105-8540
[3]
Fruscio R(2008)A SNP in a let-7 microRNA complementary site in the KRAS 3′ untranslated region increases non-small cell lung cancer risk Cancer Res 68 8535-1007
[4]
Buda A(2009)A let-7 microRNA-binding site polymorphism in the KRAS 3′ UTR is associated with reduced survival in oral cancers Carcinogenesis 30 1003-191
[5]
Broggini M(2014)MicroRNA binding site polymorphisms as biomarkers in cancer management and research Pharmgenomics Personal Med 7 173-4734
[6]
Marabese M(2015)KRAS polymorphisms are associated with survival of CRC in Chinese population Tumour Biol 37 4727-28
[7]
Cerne JZ(1999)Epidemiology of digestive tract cancers in India IV. Gall bladder and pancreas Indian J Gastroenterol 18 24-653
[8]
Stegel V(2012)Gallbladder cancer: can newer insights improve the outcome? J Gastroenterol Hepatol 27 642-35
[9]
Gersak K(2015)Role of KRAS-LCS6 polymorphism in advanced NSCLC patients treated with erlotinib or docetaxel in second line treatment (TAILOR) Sci Rep 5 16331-84
[10]
Novakovic S(2016)Epidemiological study of gallbladder cancer patients from North Indian Gangetic Planes—a high-volume centre’s experience J Gastrointest Cancer 47 27-647